Test Code LAB418 Organic Acids, Urine
Clinical System Name
Organic Acids, Urine
Synonyms
U Org Acd
Sample Requirements
Specimen: Urine
Container(s): Sterile Screw-Capped Container
Preferred Vol: 10.0 mL
Minimum Vol: 5.0 (See note)
Note: Minimum volume not defined; the department will determine if quantity is sufficient depending on creatinine concentration.
Processing Instructions
Reject due to:
Spin:N
Aliquot:Y
Temp:-20 C
Storage location: CPA Freezer, BCG Box
Off-site collection: Aliquots should be taken from a thoroughly thawed & mixed refrigerated sample. Ship frozen.
Stability
Temperature | Time |
---|---|
Room temp | ≤24 hrs |
Refrigerated | <24 hrs |
Frozen | 3 month |
Availability
STAT | Performed | TAT |
---|---|---|
N | T,F | 3-10 days |
Contact the Biochemical Genetics Lab for requests outside of stated availability (206)987-2216.
Performing Laboratory
Seattle Children's Laboratory
Department
Department: Biochemical Genetics
Phone Number: 206-987-2216
CPT Codes
83918
Methodology
Method: Gas chromatography/mass spectrometry (GC/MS)
Analytical Volume: Dependent on creatinine concentration.
Limitations:
Description
Organic acids are extracted from urine at acid pH with ethyl acetate and ether, and derivatized with hydroxylamine and BSTFA. Separation is accomplished by gas chromatography and identification by mass spectrometry using a library of 200 compounds. Semi-quantitative results are reported for 13 organic acids. Other clinically relevant organic acids will be reported if present.
Clinical Utility
Urine organic acids can be used for diagnosis and monitoring in patients with disorders of amino acid, organic acid, and fatty acid metabolism. This test is often used in conjunction with plasma acylcarnitines for follow up of presumptive positives in the newborn screening program.
The following conditions typically show abnormalities in the urine organic acid profile:
Alcaptonuria (homogentisic acid)
Biotinidase deficiency
Canavan disease (N-acetylaspartic acid)
Fatty Acid Oxidation Defects (MCAD, VLCAD, LCHAD)
Fructose-1,6-diphosphatase deficiency (glycerol)
Fumarase deficiency
Glutaric aciduria type 1 & 2
Glycerol kinase deficiency (glycerol)
Hawkinsinuria (4-hydroxycyclohexylacetic acid)
HMG CoA lyase deficiency
Holocarboxylase synthase deficiency
Hyperoxaluria type 1 & 2
Isovaleric aciduria
Ketosis
Ketothiolase deficiency
Malonyl-CoA dehydrogenase deficiency
Maple Syrup Urine Disease
Methylmalonic aciduria
3-methylcrotonyl CoA carboxylase deficiency
Mevalonic aciduria (mevalonolactone)
Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type 2)
Multiple carboxylase deficiency
Ornithine transcarbamylase deficiency (orotic acid)
Phenylketonuria
Propionic aciduria
Succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric acid)
Tyrosinemia type 1 (succinylacetone)
Tyrosinemia type 2
Special Instructions
Samples are best collected while patient is ill. Testing asymptomatic patients may yield false negative results. Succinylacetone is included in this test, however, please note if tyrosinemia type 1 is suspected. Order quantitative succinylacetone for follow-up monitoring of confirmed patients.
Requisition
Biochemical Genetics Requisition
On the requisition include clinical inforamtion needed for appropriate interpretation. (Age, gender, diet (e.g. TPN therapy), drug therapy and family history)
Reference Ranges
Reference ranges for urine organic acid excretion (semi-quant) |
|||
Organic Acid |
<1 mo |
1 mo-1 yr |
>1 yr |
|
Approximate concentration (mg/g creatinine) |
||
LACTIC |
<125 |
<95 |
<60 |
PYRUVIC |
<60 |
<60 |
<50 |
3-OH-BUTYRIC |
<50 |
<50 |
<50 |
ACETOACETIC |
<25 |
<25 |
<25 |
ETHYLMALONIC |
<32 |
<26 |
<19 |
FUMARIC |
<45 |
<30 |
<30 |
GLUTARIC |
<20 |
<28 |
<28 |
3-METHYLGLUTARIC |
<10 |
<10 |
<10 |
3-METHYLGLUTACONIC |
<22 |
<22 |
<22 |
ADIPIC |
<24 |
<40 |
<25 |
2-KETOGLUTARIC |
<745 |
<275 |
<153 |
SUBERIC |
<42 |
<46 |
<32 |
SEBACIC |
<36 |
<36 |
<14 |